IL-35 EBI3 Biotin Conjugated Antibody, IgG2b, Clone: [V1.4F5.25], Mouse, Monoclonal

Artikelnummer: ROC-210-306-C56
Artikelname: IL-35 EBI3 Biotin Conjugated Antibody, IgG2b, Clone: [V1.4F5.25], Mouse, Monoclonal
Artikelnummer: ROC-210-306-C56
Hersteller Artikelnummer: 210-306-C56
Alternativnummer: ROC-210-306-C56
Hersteller: Rockland Immunochemicals
Wirt: Mouse
Kategorie: Antikörper
Applikation: NeA
Spezies Reaktivität: Mouse
Immunogen: Anti-EBI-3 (MOUSE) Monoclonal Antibody was produced in mouse by repeated immunizations with mature full length recombinant mouse EBI-3 produced in E.coli followed by hybridoma development.
Konjugation: Biotin
Alternative Synonym: mouse anti-EBI3 biotin conjugated antibody, mouse anti-IL-35 biotin conjugated antibody, Epstein-Barr virus induced 3 protein, Interleukin-27 subunit beta, IL-27 subunit beta, IL-27B, Epstein-Barr virus-induced gene 3 protein, EBV-induced gene 3 protein, EBI-3, EBI3, IL-35, IL35
Klonalität: Monoclonal
Konzentration: 1.0 mg/mL by UV absorbance at 280 nm
Klon-Bezeichnung: [V1.4F5.25]
Isotyp: IgG2b
NCBI: 50498
UniProt: O35228
Puffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Formulierung: Lyophilized
Target-Kategorie: Mouse
Antibody Type: Primary Antibody
Application Verdünnung: ELISA: 1:10,000, IP: 1µg/mL, WB: 1:1000
Anwendungsbeschreibung: This purified antibody has been tested in Neutralization and suitable for IP. Specific conditions for reactivity should be optimized by the end user.
Neutralization: Human CD4+CD25- (Tconv) were purified by FACS from cord blood, activated with anti-CD3/CD28-coated beads and 10IU IL-2 in the presence of human IL-35 and a titration of an isotype control or 210-301-C56 antibody. Percent neutralization was determined by calculating the percent decrease in counts per minute of activated Tconv plus (0%) or minus (100%) human IL-35 in the presence and absence of Ab.
Neutralization: Murine CD4+CD25- (Tconv) were purified by FACS, activated with anti-CD3/CD28-coated beads in the presence of a titration of mouse IL-35 and 10µg/mL of 210-301-C56 antibody. Percent suppression was determined by calculating the percent decrease in counts per minute of activated Tconv plus or minus murine IL-35.